GG 537 (Bromocriptine mesylate 5 mg)
Pill imprint GG 537 has been identified as Bromocriptine mesylate 5 mg.
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; acromegaly; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- GG 537
- Strength:
- 5 mg
- Color:
- White & Yellow
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-2119
- Inactive Ingredients:
- silicon dioxide
gelatin
lactose
magnesium stearate
ferric oxide red
sodium lauryl sulfate
corn starch
titanium dioxide
ferric oxide yellow
More about bromocriptine
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
